Zynex Corp (ZYXI) - Long-Term Debt to Capital Coefficient

Corporate emblem and logo of Zynex, Inc. (ZYXI)

Zynex, Inc. (ZYXI) relies on external component suppliers while performing the final assembly of electrotherapy devices in-house. The long-term debt-to-equity ratio trend illustrates the financial leverage, where 0.00 is recorded as the baseline value. Critically assessing expansion through agent recruitment and margin growth, one should note the risks of dependency on the NexWave home rehabilitation ecosystem they have established.

ZYXI Zynex Medical: Long-Term Debt to Equity in the range 07/04/2022 - 01/03/2026
Core merchandise of Zynex Corp

An investor is assessing the long-term sustainability of Zynex, Inc. (ZYXI) through an analysis of its credit load. This metric compares the volume of liabilities with a maturity of more than one year against equity. The trend in the long-term debt-to-equity ratio reflects the business's degree of dependence on external financing. A decrease in this ratio minimizes the risk of default. Financial autonomy is critically important for Zynex, Inc. (ZYXI) as it diversifies into the respiratory monitoring segment amid the saturation of the electrostimulation market.

Competing companies

DXCM (DexCom Inc) - Long-Term Loans to Capital Ratio|Long-Term Debt to Capital PEN|NOVT (Novanta Photonics) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital HAE (Haemonetics Corporation)|inspiresleep.com (INSP) - Long-Term Liabilities to Capital|PRCT - Long-Term Debt to Equity|Long-Term Debt to Capital Coefficient CNMD (CONMED Corp)|PLSE: Long-Term Debt to Capital|InMode MD (INMD) - Long-Term Debt to Capital|Long-Term Debt to Equity Picard Medical Inc|surmodics.com - Long-Term Liabilities to Equity|Long-Term Debt to Capital SENS|NPCE - Long-Term Liabilities to Capital|Tactile Medical - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital SANUWAVE Health Inc SNWV|OM: Long-Term Debt to Equity Ratio|Electromed, Inc. - Long-Term Loans to Capital Ratio|LNSR: Long-Term Debt to Capital|RCEL - Ratio of Long-Term Indebtedness to Capital|PROF (Profound Medical Corp) - Long-Term Debt to Capital|Long-Term Debt to Equity Ratio Baird Medical Corp (BDMD)|Long-Term Debt to Equity Ratio EDAP (EDAP TMS S.A.)|APYX (apyxmedical.com) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Equity IceCure Medical ICCM|LUNG - Long-Term Debt to Equity Ratio|TELA Bio Corp - Long-Term Debt to Capital|Long-Term Liabilities to Capital Cytosorbents|SRTS: Long-Term Debt to Capital|Long-Term Debt to Capital Ratio ECOR|RBOT (Vicarious Surgical Inc) - Long-Term Debt to Capital|Inspira Technologies Oxy B.H.N. Ltd (IINN) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Capital ICU|Long-Term Debt to Equity Ratio iridex.com IRIX|Long-Term Debt to Capital INBS (Intelligent Bio Solutions Inc.)|Long-Term Debt to Capital Beyond Air Inc XAIR|PFSA - Long-Term Debt to Equity|SSKN: Long-Term Debt to Equity|GCTK (GlucoTrack) - Long-Term Debt to Equity Ratio|NanoVibronix Inc. - Long-Term Debt to Capital Coefficient|VERO (Venus Concept Inc.) - Long-Term Debt to Capital|Long-Term Liabilities to Capital nuwellis.com NUWE|Long-Term Debt to Equity Aethlon Medical, Inc. (AEMD)|asensus.com (ASXC) - Long-Term Indebtedness to Equity|Avinger, Inc - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital BioSig Technologies Inc. BSGM|Cutera, Inc. - Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital knowlabs.co KNW|Inari Medical (NARI) - Long-Term Debt to Equity|Long-Term Liabilities to Equity NVRO (Nevro Corp)|Long-Term Debt to Equity ReShape Lifesciences, Inc.|Long-Term Debt to Equity Ratio Silk Road Medical Inc (SILK)